P1.09-011 LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients With Malignant Pleural Mesothelioma
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2017.09.984
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2017
Authors
Publisher
Elsevier BV